Results 91 to 100 of about 132,876 (138)

All for one or one for all! [PDF]

open access: yesREC Interv Cardiol
Camm AJ.
europepmc   +1 more source

Aprotinina: ¿Un fármaco multifuncional?

open access: yes, 2005
El empleo de fármacos promotores de la hemostasia se considera de gran importancia adyuvante en el manejo del sangrado. En el momento de la publicación de este capítulo, la aprotinina, un fármaco básicamente antifibrinolítico, se consideraba un paso ...
Alcántara, Mª José, Llau, Juan V.
core  

Interacciones Fármaco-Gén en Cáncer Oro-Digestivo mediante Inhibidores de Histona Demetilasas

open access: yes
Introduction: Histone demethylase inhibitors (HDMIs) target histone demethylase enzymes, which play a key role in regulating gene expression. Quantum machine learning, particularly Variational Quantum Classifiers (VQCs), offers potential advantages by ...
Ardila, Carlos M.   +2 more
core   +1 more source

[Study of anticholinergic burden in chronic treatments of outpatients in the Community Pharmacy]. [PDF]

open access: yesFarm Comunitarios
Zaragoza Noguera R   +2 more
europepmc   +1 more source

[Strategy to optimize patient safety in the community pharmacy dispensing service. Proposed checklists]. [PDF]

open access: yesFarm Comunitarios, 2023
Adsuar-Meseguer GM   +9 more
europepmc   +1 more source

[Advances and guidance in the treatment of drug-resistant epilepsy: a review by the Andalusian Epilepsy Society of the new drugs cenobamate, fenfluramine and cannabidiol]. [PDF]

open access: yesRev Neurol
Arenas-Cabrera C   +7 more
europepmc   +1 more source

[Frequency of cutaneous drug reactions in the outpatient dermatology clinic at the National Institute of Cardiology Ignacio Chávez over a ten-year period]. [PDF]

open access: yesArch Cardiol Mex
Coria-Vázquez S   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy